Mette Møller

Mette Møller serves as a Physician Scientist at the Department of Oncology within the Faculty of Medicine at Aalborg University Hospital, Aalborg University. Her clinical and research work centers on advancing breast cancer radiotherapy techniques and patient-centered care protocols.

Her primary research domains include Breast Cancer Radiotherapy, Shared Decision Making in Oncology, Partial Breast Irradiation, Medical Physics applications, and Lymph Node Targeting. She focuses on optimizing treatment precision through auto-segmentation models, respiratory gating techniques, and evidence-based patient decision aids within the Danish Breast Cancer Group (DBCG) framework.

Analysis of her 2023-2024 publications reveals three dominant research trajectories: (1) Technical innovation in radiotherapy planning (auto-segmentation models, respiratory gating), (2) Clinical implementation of shared decision-making tools across multicenter trials, and (3) PET-guided nodal boost strategies for high-risk patients. Her work consistently bridges medical physics, clinical oncology, and patient psychology through DBCG collaborative frameworks.

Scientific awards: No awards were documented in the provided materials.

Møller actively participates in DBCG clinical trials (RT SDM, PBI) as a core research collaborator but no graduate student supervision or grant leadership is indicated. Her contributions primarily involve protocol development, data analysis, and clinical implementation within large-scale national studies.

She operates within Aalborg University Hospital's oncology division as part of the Danish Breast Cancer Group network, contributing to national consensus guidelines for breast cancer radiotherapy. Her work emphasizes interdisciplinary collaboration between radiation oncologists, medical physicists, and patient advocacy groups to standardize treatment protocols across Danish cancer centers.